PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
34.15
-0.46 (-1.33%)
Oct 8, 2025, 12:04 PM EDT - Market open
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 7 analysts that cover PROCEPT BioRobotics stock have a consensus rating of "Buy" and an average price target of $70, which forecasts a 104.98% increase in the stock price over the next year. The lowest target is $55 and the highest is $95.
Price Target: $70 (+104.98%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 2, 2025.
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $60 | Hold → Buy | Upgrades | $60 | +75.70% | Sep 2, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $58 | Buy | Maintains | $75 → $58 | +69.84% | Aug 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $80 → $55 | Buy | Maintains | $80 → $55 | +61.05% | Aug 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $71 → $68 | Buy | Maintains | $71 → $68 | +99.12% | Jul 15, 2025 |
Financial Forecast
Revenue This Year
333.10M
from 224.50M
Increased by 48.38%
Revenue Next Year
435.92M
from 333.10M
Increased by 30.87%
EPS This Year
-1.52
from -1.75
EPS Next Year
-1.00
from -1.52
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 354.2M | 455.4M | |||
| Avg | 333.1M | 435.9M | |||
| Low | 318.9M | 407.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.8% | 36.7% | |||
| Avg | 48.4% | 30.9% | |||
| Low | 42.0% | 22.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.52 | -0.43 | |||
| Avg | -1.52 | -1.00 | |||
| Low | -1.48 | -1.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.